Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Smith (Princeton, United States of America), J. Kim (Princeton, United States of America), D. Donnelly (Princeton, United States of America), A. Andrea Olga Shorts (Princeton, United States of America), T. Petrone (Princeton, United States of America), S. Kalinowski (Princeton, United States of America), B. Murphy (Princeton, United States of America), P. Cheng (Princeton, United States of America), T. Correll (Princeton, United States of America), P. Chow (Princeton, United States of America), S. Shuyan Du (Princeton, United States of America), S. Bonacorsi (Princeton, United States of America), W. Hayes (Princeton, United States of America). BMS-986327 as a novel PET imaging agent for assessment of LPA1 receptors in IPF. 1399

Member's Comments

No comment yet.

Related content which might interest you: Visualization and quantification of muscarinic receptors by positron emission tomography (PET) in human lung in vivo Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Emerging diagnostics from MRI, PET and CT studies of lung disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Long-term results obtained by cardiovascular magnetic resonance imaging and somatostatin receptor PET in cardiac sarcoidosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Downregulation of the peripheral benzodiazepine receptor in macrophages (Mφ) measured by positron emission tomography (PET) in fibrosing alveolitis due to systemic sclerosis Source: Eur Respir J 2003; 22: Suppl. 45, 532s Year: 2003 In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma Source: Eur Respir J 2003; 21: 567-573 Year: 2003 MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases. Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Late Breaking Abstract - A PET imaging study to confirm target engagement in the lungs of patients with IPF following a single dose of a novel inhaled avß6 integrin inhibitor Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 LPA1 antagonist BMS-986278 for idiopathic pulmonary fibrosis: Preclinical pharmacological in vitro and in vivo evaluation Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Diagnostic imaging of lung cancer Source: Eur Respir J 2002; 19: 722-742 Year: 2002 Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques Source: Eur Respir J 2007; 29: 418-422 Year: 2007 LPA1 antagonists BMS-986020 and BMS-986234 for idiopathic pulmonary fibrosis: Preclinical evaluation of hepatobiliary homeostasis Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Diagnostic imaging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=120 Year: 2001 Magnetic resonance imaging (MRI) of the lung as a tool for the non-invasive evaluation of drugs in rat models of airways diseases Source: Annual Congress 2005 - New modalities and application in lung and airway imaging Year: 2005 Value of MR imaging in the early detection of cardiac involvement in sarcoidosis Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 The use of perfusion SPECT imaging for preoperative evaluation of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 38s Year: 2002 New imaging techniques in the treatment guidelines for lung cancer Source: Eur Respir J 2002; 19: 71S-83S Year: 2002 Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009 Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 The value of magnetic resonance imaging (MRI) with gadolinium as a noninvasive diagnostic method in cardiac sarcoidosis Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008